A cluster‑randomized clinical trial published in The BMJ found that an AI‑driven clinical decision support system (CDSS) improved care quality and long‑term outcomes for patients with acute ischemic stroke in China. The trial evaluated the CDSS across participating hospitals and reported measurable gains in guideline adherence and patient outcomes compared with standard care. Authors highlight that AI can standardize assessments and recommendations in time‑sensitive settings like stroke, but they also flagged integration, clinician acceptance, and validation across diverse healthcare systems as necessary steps before broader adoption.